Products
11
Risk 4 marker(s) are high/abnormal. Keep protocol changes conservative and confirm with a clinician.
Queue 2 pending/conditional change(s) are listed. Apply sequentially and track response.
Timeline Next labwork target: 2026-05-22. Latest status: Completed - reviewed.
Products
11
Total pills / day
26
Morning pills
14
Evening pills
12
Ingredients
24
Pending changes
2
Morning schedule
14 pills
Evening schedule
12 pills